Literature DB >> 8501353

Heterotopic autotransplantation of a pancreas segment with enteric drainage after total or subtotal pancreatectomy for chronic pancreatitis.

K Tamura1, S Yano, S Kin, H Nagami, M Itakura, M Nakagawa, A Nakase, R Tsuchiya.   

Abstract

Four patients with chronic alcoholic pancreatitis and one patient with idiopathic chronic pancreatitis, who had total or subtotal distal pancreatectomies for persistent pain, underwent simultaneous autotransplantation of a pancreas segment to preserve the pancreatic function. The segment was autotransplanted heterotopically to the iliac fossa with anastomosis of the splenic vessels to the iliac vessels to prevent reinnervation, and the pancreatic duct was anastomosed to the intestine to preserve exocrine function. Postoperatively, the patency of the graft vessels was confirmed by angiography in every patient. Complete pain relief has been obtained in all patients with a followup duration of 4-89 mo. Except for one patient who had been treated preoperatively with insulin injections for diabetes, the patients remained normoglycemic without exogenous insulin administration and demonstrated satisfactory insulin secretion during a 75-g oral glucose tolerance test. An exocrine pancreatic diagnostant test using p-aminobenzoic acid yielded nearly similar levels to the preoperative value for all patients. Heterotopic autotransplantation of the pancreas segment appears to be effective for preserving pancreatic function, as well as providing permanent pain relief for patients with chronic pancreatitis who require extensive resection of the pancreas.

Entities:  

Mesh:

Year:  1993        PMID: 8501353     DOI: 10.1007/BF02786080

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  19 in total

1.  Pancreatectomy for chronic pancreatitis.

Authors:  C F Frey; C G Child; W Fry
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

2.  Gastric secretion in patients with chronic pancreatitis and in chronic alcoholics.

Authors:  W Y Chey; O Kusakcioglu; V Dinoso; S H Lorber
Journal:  Arch Intern Med       Date:  1968-11

3.  Peptic ulcer diathesis in patients with chronic pancreatitis.

Authors:  D A Dreiling; M A Naqvi
Journal:  Am J Gastroenterol       Date:  1969-06       Impact factor: 10.864

4.  Determination of the glycosylated hemoglobins (HB AI) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus.

Authors:  E C Abraham; T A Huff; N D Cope; J B Wilson; E D Bransome; T H Huisman
Journal:  Diabetes       Date:  1978-09       Impact factor: 9.461

5.  The effect of duct obliteration on the histology and endocrine function of the canine pancreas.

Authors:  H G Gooszen; F T Bosman; R van Schilfgaarde
Journal:  Transplantation       Date:  1984-07       Impact factor: 4.939

6.  Gastric secretion of acid in patients with pancreatic disease.

Authors:  J H Saunders; J M Cargill; K G Wormsley
Journal:  Digestion       Date:  1978 Jul-Aug       Impact factor: 3.216

7.  Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis.

Authors:  A C Farney; J S Najarian; R E Nakhleh; G Lloveras; M J Field; P F Gores; D E Sutherland
Journal:  Surgery       Date:  1991-08       Impact factor: 3.982

8.  Segmental pancreatic autotransplantation for chronic pancreatitis. A preliminary report.

Authors:  R L Rossi; J W Braasch; E M O'Bryan; E Watkins
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

9.  Surgical management of chronic pancreatitis: long-term results in 141 patients.

Authors:  A Mannell; M A Adson; D C McIlrath; D M Ilstrup
Journal:  Br J Surg       Date:  1988-05       Impact factor: 6.939

10.  Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis.

Authors:  J S Najarian; D E Sutherland; D Baumgartner; B Burke; J J Rynasiewicz; A J Matas; F C Goetz
Journal:  Ann Surg       Date:  1980       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.